Research in Social and Administrative Pharmacy
Volume 8, Issue 1 , Pages 4-16 , January 2012

Consumer perspectives of the Australian Home Medicines Review Program: Benefits and barriers

  • Lesley White, B.Pharm., M.Com., M.Ed., Ph.D.

      Affiliations

    • Faculty of Business, Charles Sturt University, Bathurst, NSW 2795, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9351 4447; fax: +61 2 9351 4391.
    • ,
  • Christiane Klinner, Grad Dipl Mmt, Grad Cert QHR

      Affiliations

    • Centre for Values, Ethics and the Law in Medicine (VELiM), Faculty of Medicine, University of Sydney, NSW 2006, Australia
    • ,
  • Stephen Carter, BPharm, MSc

      Affiliations

    • Faculty of Pharmacy, University of Sydney, Sydney, NSW 2006, Australia

References 

  1. Bennett A, Smith C, Chen T, Johnsen S, Hurst R. A comparative study of two collaborative models for the provision of domiciliary medication review: St George Canterbury Medico/Pharmacy Projectd–executive report. Available at: http://www.guild.org.au/mmr/content.asp?id=406. Accessed November 2009.
  2. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother. 2009;43:1096–1106
  3. Holland R, Desborough J, Goodyer L, Hall S, Wright D, Loke YK. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65:303–316
  4. Lowe CJ, Raynor DK, Purvis J, Farrin A, Hudson J. Effects of a medicine review and education programme for older people in general practice. Br J Clin Pharmacol. 2000;50:172–175
  5. Sorensen L, Stokes JA, Purdie DM, Woodward M, Elliott R, Roberts MS. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58:648–664
  6. Yu K, Nguyen A, Shakib S, et al. Enhancing continuity of care in therapeutics: development of a post-discharge home medicines review model. J Pharm Pract Res. 2007;37:22–26
  7. Quirke J, Wheatland B, Gilles M, Howden A, Larson A. Home medicines reviews: do they change prescribing and patient/pharmacist acceptance?. Aust Fam Physician. 2006;35:266–267
  8. Campbell Research & Consulting . Home Medicines Review Program, Qualitative Research Project, Final Report. Department of Health and Aging; 2008;http://www.guild.org.au/mmr/content.asp?id=406. Accessed November 2009
  9. Schwartzkoff J, et al. for Urbis, Keys, Young Evaluation of the Home Medicines Review Program—Pharmacy Component, Investigator Initiated Guild Government Grant 2004-526. The Pharmacy Guild of Australia; 2005;Canberra BC ACT 2610, Available at: http://www.guild.org.au/research/project_display.asp?id=277. Accessed November 2009
  10. Roberts A, Benrimoj C, Chen T, Williams K, Aslani P. Quantification of Facilitators to Accelerate Uptake of Cognitive Pharmaceutical Services (CPS) in Community Pharmacy, Investigator Initiated Guild Government Grant 2003-007. The Pharmacy Guild of Australia; 2004;The University of Sydney, Sydney, NSW 2006; Available at: http://www.guild.org.au/research/project_display.asp?id=263. Accessed November 2009
  11. Chen T, Larkin C. Consumer attitudes toward and experiences of domiciliary visits by community pharmacists. Aust Pharm. 2002;21:682–684686–688
  12. Fogg S. Consumer Evaluation of Domiciliary Medication Management Reviews. Consumers’ Health Forum; 2001;
  13. Huston SA, Hobson EH. Using focus groups to inform pharmacy research. Res Social Adm Pharm. 2008;4:186–205
  14. Liamputtong P. Qualitative data analysis: conceptual and practical considerations. Health Promot J Austr. 2009;20:133–139
  15. Roughead E, Pratt N, Peck R, Gilbert A. Improving medication safety: influence of a patient-specific prescriber feedback program on rate of medication reviews performed by Australian general medical practitioners. Pharmacoepidemiol Drug Saf. 2007;16:797–803
  16. Smith F, Francis S-A, Gray N, Denham M, Graffy J. A multi-centre survey among informal carers who manage medication for older care recipients: problems experienced and development of services. Health Soc Care Community. 2003;11:138–145
  17. Ranelli PL, Hansen RW. Medication-Related Stressors and the Family Caregiver: A Qualitative Analysis. Res Sociol Health Care. 1997;14:233–248
  18. Harrison J, Haddad P, Maguire P. The impact of cancer on key relatives: a comparison of relative and patient concerns. Eur J Cancer. 1995;31:1736–1740
  19. Brown M-A, Stetz K. The labor of caregiving: a theoretical model of caregiving during potentially fatal illness. Qual Health Res. 1999;9:182–197
  20. Grahn G, Danielson M. Coping with the cancer experience. II. Evaluating an education and support programme for cancer patients and their significant others. Eur J Cancer Care (Engl). 1996;5:182–187
  21. Morris SM, Thomas C. The need to know: informal carers and information. Eur J Cancer Care (Engl). 2002;11:183–187
  22. Walker E, Dewar BJ. How do we facilitate carers’ involvement in decision making?. J Adv Nurs. 2001;34:329–337
  23. Winstanley S, Thompson B, Harper A, Hudson E. Users and carers views about health services. J Community Nurs. 2004;18:4
  24. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs. 2005;49:616–623
  25. Grande GE, Myers LB, Sutton SR. How do patients who participate in cancer support groups differ from those who do not?. Psychooncology. 2006;15:321–334
  26. Hollander JA. The social context of focus groups. J Contemp Ethnogr. 2004;33:602–637
  27. Kitzinger J. Introducing focus groups. BMJ. 1995;311:299

PII: S1551-7411(10)00166-X

doi: 10.1016/j.sapharm.2010.11.003

Research in Social and Administrative Pharmacy
Volume 8, Issue 1 , Pages 4-16 , January 2012

Article Tools